Vous pouvez maintenant accéder à la version de decembre 2024 du Répertoire canadien des médicaments à partir de Terminology Gateway et du serveur terminologique, à des fins de consultation ou d’implantation.
En savoir plus >
We'd like to hear your thoughts about the naming of biologic drugs including biosimilars. This questionnaire consists of 5 questions.
Access the Consultation and Questionnaire link below: lnkd.in/dZFZXc9
Your responses before February 9th, to this consultation questionnaire will help to inform the development of Health Canada's naming policy to distinguish among biologic drugs that share the same non-proprietary name.